FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210366542> ?p ?o ?g. }

• W4210366542 abstract "Abstract Background Studies have reported an increased risk of mortality among people prescribed mirtazapine compared to other antidepressants. The study aimed to compare all-cause and cause-specific mortality between adults prescribed mirtazapine or other second-line antidepressants. Methods This cohort study used English primary care electronic medical records, hospital admission records, and mortality data from the Clinical Practice Research Datalink (CPRD), for the period 01 January 2005 to 30 November 2018. It included people aged 18–99 years with depression first prescribed a selective serotonin reuptake inhibitor (SSRI) and then prescribed mirtazapine (5081), a different SSRI (15,032), amitriptyline (3905), or venlafaxine (1580). Follow-up was from starting to stopping the second antidepressant, with a 6-month wash-out window, censoring at the end of CPRD follow-up or 30 November 2018. Age-sex standardised rates of all-cause mortality and death due to circulatory system disease, cancer, or respiratory system disease were calculated. Survival analyses were performed, accounting for baseline characteristics using inverse probability of treatment weighting. Results The cohort contained 25,598 people (median age 41 years). The mirtazapine group had the highest standardised mortality rate, with an additional 7.8 (95% confidence interval (CI) 5.9–9.7) deaths/1000 person-years compared to the SSRI group. Within 2 years of follow-up, the risk of all-cause mortality was statistically significantly higher in the mirtazapine group than in the SSRI group (weighted hazard ratio (HR) 1.62, 95% CI 1.28–2.06). No significant difference was found between the mirtazapine group and the amitriptyline (HR 1.18, 95% CI 0.85–1.63) or venlafaxine (HR 1.11, 95% CI 0.60–2.05) groups. After 2 years, the risk was significantly higher in the mirtazapine group compared to the SSRI (HR 1.51, 95% CI 1.04–2.19), amitriptyline (HR 2.59, 95% CI 1.38–4.86), and venlafaxine (HR 2.35, 95% CI 1.02–5.44) groups. The risks of death due to cancer (HR 1.74, 95% CI 1.06–2.85) and respiratory system disease (HR 1.72, 95% CI 1.07–2.77) were significantly higher in the mirtazapine than in the SSRI group. Conclusions Mortality was higher in people prescribed mirtazapine than people prescribed a second SSRI, possibly reflecting residual differences in other risk factors between the groups. Identifying these potential health risks when prescribing mirtazapine may help reduce the risk of mortality." @default.
• W4210366542 created "2022-02-08" @default.
• W4210366542 creator A5003031084 @default.
• W4210366542 creator A5004448187 @default.
• W4210366542 creator A5013162603 @default.
• W4210366542 creator A5015908289 @default.
• W4210366542 creator A5019180557 @default.
• W4210366542 creator A5066706117 @default.
• W4210366542 creator A5080823270 @default.
• W4210366542 creator A5088425067 @default.
• W4210366542 date "2022-02-02" @default.
• W4210366542 modified "2023-10-14" @default.
• W4210366542 title "The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records" @default.
• W4210366542 cites W1849521086 @default.
• W4210366542 cites W1985359478 @default.
• W4210366542 cites W2000445173 @default.
• W4210366542 cites W2044170764 @default.
• W4210366542 cites W2056108924 @default.
• W4210366542 cites W2101364543 @default.
• W4210366542 cites W2119852447 @default.
• W4210366542 cites W2161743657 @default.
• W4210366542 cites W2168458505 @default.
• W4210366542 cites W2292607455 @default.
• W4210366542 cites W2301478960 @default.
• W4210366542 cites W2567007802 @default.
• W4210366542 cites W2599457655 @default.
• W4210366542 cites W2755651830 @default.
• W4210366542 cites W2770112230 @default.
• W4210366542 cites W2792485919 @default.
• W4210366542 cites W2793831746 @default.
• W4210366542 cites W2796479708 @default.
• W4210366542 cites W2895933916 @default.
• W4210366542 cites W2937983702 @default.
• W4210366542 cites W2963955749 @default.
• W4210366542 cites W2972667450 @default.
• W4210366542 cites W2992179715 @default.
• W4210366542 cites W2999752059 @default.
• W4210366542 cites W3017058566 @default.
• W4210366542 cites W3094010270 @default.
• W4210366542 cites W3113691763 @default.
• W4210366542 cites W3126335111 @default.
• W4210366542 cites W3161105514 @default.
• W4210366542 cites W3186906491 @default.
• W4210366542 cites W4236098165 @default.
• W4210366542 cites W4241933026 @default.
• W4210366542 cites W4247818158 @default.
• W4210366542 doi "https://doi.org/10.1186/s12916-022-02247-x" @default.
• W4210366542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35105363" @default.
• W4210366542 hasPublicationYear "2022" @default.
• W4210366542 type Work @default.
• W4210366542 citedByCount "1" @default.
• W4210366542 countsByYear W42103665422023 @default.
• W4210366542 crossrefType "journal-article" @default.
• W4210366542 hasAuthorship W4210366542A5003031084 @default.
• W4210366542 hasAuthorship W4210366542A5004448187 @default.
• W4210366542 hasAuthorship W4210366542A5013162603 @default.
• W4210366542 hasAuthorship W4210366542A5015908289 @default.
• W4210366542 hasAuthorship W4210366542A5019180557 @default.
• W4210366542 hasAuthorship W4210366542A5066706117 @default.
• W4210366542 hasAuthorship W4210366542A5080823270 @default.
• W4210366542 hasAuthorship W4210366542A5088425067 @default.
• W4210366542 hasBestOaLocation W42103665421 @default.
• W4210366542 hasConcept C126322002 @default.
• W4210366542 hasConcept C167135981 @default.
• W4210366542 hasConcept C201903717 @default.
• W4210366542 hasConcept C207103383 @default.
• W4210366542 hasConcept C2776466888 @default.
• W4210366542 hasConcept C2779177272 @default.
• W4210366542 hasConcept C2781068410 @default.
• W4210366542 hasConcept C2781161787 @default.
• W4210366542 hasConcept C44249647 @default.
• W4210366542 hasConcept C50382708 @default.
• W4210366542 hasConcept C71924100 @default.
• W4210366542 hasConcept C72563966 @default.
• W4210366542 hasConceptScore W4210366542C126322002 @default.
• W4210366542 hasConceptScore W4210366542C167135981 @default.
• W4210366542 hasConceptScore W4210366542C201903717 @default.
• W4210366542 hasConceptScore W4210366542C207103383 @default.
• W4210366542 hasConceptScore W4210366542C2776466888 @default.
• W4210366542 hasConceptScore W4210366542C2779177272 @default.
• W4210366542 hasConceptScore W4210366542C2781068410 @default.
• W4210366542 hasConceptScore W4210366542C2781161787 @default.
• W4210366542 hasConceptScore W4210366542C44249647 @default.
• W4210366542 hasConceptScore W4210366542C50382708 @default.
• W4210366542 hasConceptScore W4210366542C71924100 @default.
• W4210366542 hasConceptScore W4210366542C72563966 @default.
• W4210366542 hasFunder F4320319990 @default.
• W4210366542 hasIssue "1" @default.
• W4210366542 hasLocation W42103665421 @default.
• W4210366542 hasLocation W42103665422 @default.
• W4210366542 hasLocation W42103665423 @default.
• W4210366542 hasLocation W42103665424 @default.
• W4210366542 hasLocation W42103665425 @default.
• W4210366542 hasLocation W42103665426 @default.
• W4210366542 hasOpenAccess W4210366542 @default.
• W4210366542 hasPrimaryLocation W42103665421 @default.
• W4210366542 hasRelatedWork W2026094606 @default.
• W4210366542 hasRelatedWork W2071306276 @default.
• W4210366542 hasRelatedWork W2084877542 @default.
• W4210366542 hasRelatedWork W2316506268 @default.

• next